ImageneBio Reports Q3 2026 Net Loss of $15.6 Million
ImageneBio reported a $15.6 million net loss for the third quarter of 2026, versus $24.8 million a year earlier. It ended September with $126.6 million in cash, cash equivalents and marketable securities, which it expects to fund planned operations into the first quarter of 2028.
ImageneBio reported a net loss of $15.6 million for the third quarter of 2026, compared with $24.8 million a year earlier. The company ended September with $126.6 million in cash, cash equivalents and marketable securities, which it expects to fund planned operations into the first quarter of 2028…